LIraglutide and Beta-cell RepAir (LIBRA) Study

NCT01270789 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Liraglutide
DRUG: placebo

Sponsor

Mount Sinai Hospital, Canada

Collaborators

[object Object]